The Association of Indian Medical Device Industry (AiMeD) has lauded the Uttar Pradesh government for its move to strengthen the clinical research ecosystem for medical devices through the UP Shruti (MRAS) Workshop and the launch of the Uttar Pradesh Integrated Medical Research Application System (UP-MRAS). The workshop, held at Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, brought together senior representatives from government, academia, industry and Contract Research Organizations (CROs), signalling a coordinated push toward a more efficient and transparent research framework in the state.
Welcoming the initiative, Rajiv Nath, Forum Coordinator, AiMeD, said the rollout of UP‑MRAS represents a forward-looking approach to building a unified, digital and transparent clinical research ecosystem for medical devices. According to him, such platforms can play a critical enabling role for the Indian MedTech sector by expediting clinical validation, regulatory approvals and the commercialization of indigenously developed devices. He noted that the sector has historically been constrained by fragmented clinical processes and delays, largely because regulators tend to apply drug‑style clinical trial procedures to medical devices, which have different risk and evaluation profiles.
Nath highlighted that initiatives like UP‑MRAS, backed by standard operating procedures (SOPs) tailored specifically for medical devices and clearly differentiated from drugs, can help build trust, improve compliance and offer a predictable pathway for innovators. A more streamlined and device‑appropriate regulatory approach is expected to accelerate innovation while enhancing India’s ability to compete in the global medical devices market. In particular, faster, clearer routes from proof‑of‑concept to clinical validation and market approval could substantially reduce time to market for domestic manufacturers.
The UP‑MRAS platform, demonstrated during the workshop, is designed to digitise and streamline research workflows, including online submission of proposals and improved coordination among ethics committees, investigators and regulators. By introducing standardized processes and an integrated regulatory pathway, the system aims to compress timelines for clinical studies and approvals, an area long identified as a bottleneck for the growth of India’s medical device industry. AiMeD underlined that such digital integration can also improve traceability, documentation quality and oversight across the clinical research lifecycle.
AiMeD further stressed that deeper collaboration between government institutions, academic centres and industry, as showcased at the workshop, will be central to building a robust, future‑ready clinical research ecosystem. Better alignment of regulatory frameworks, clearer guidance specific to devices and stronger data management capabilities are expected to raise both the quality and reliability of clinical evidence generated in Uttar Pradesh.
AiMeD reiterated that Uttar Pradesh’s initiative can serve as a template for other states, particularly in designing device‑specific research pathways that support the Government of India’s Atmanirbhar Bharat vision in healthcare. By fostering innovation, manufacturing and clinical research within the country, such models can help position India as a global hub for medical device development and evidence‑based deployment.
